Rossi Sabrina H, McQuarrie Emily P, Miller William H, Mackenzie Ruth M, Dymott Jane A, Moreno María U, Taurino Chiara, Miller Ashley M, Neisius Ulf, Berg Geoffrey A, Valuckiene Zivile, Hannay Jonathan A, Dominiczak Anna F, Delles Christian
BMC Nephrol. 2013 Aug 13;14:173. doi: 10.1186/1471-2369-14-173.
Chronic kidney disease (CKD) and coronary artery disease (CAD) are independently associated with increased vascular stiffness. We examined whether renal function contributes to vascular stiffness independently of CAD status.
We studied 160 patients with CAD and 169 subjects without CAD. The 4-variable MDRD formula was used to estimate glomerular filtration rate (eGFR); impaired renal function was defined as eGFR <60 mL/min. Carotid-femoral pulse wave velocity (PWV) was measured with the SphygmoCor® device. Circulating biomarkers were assessed in plasma using xMAP® multiplexing technology.
Patients with CAD and impaired renal function had greater PWV compared to those with CAD and normal renal function (10.2 [9.1;11.2] vs 7.3 [6.9;7.7] m/s; P < 0.001). In all patients, PWV was a function of eGFR (β = -0.293; P < 0.001) even after adjustment for age, sex, systolic blood pressure, body mass index and presence or absence of CAD. Patients with CAD and impaired renal function had higher levels of adhesion and inflammatory molecules including E-selectin and osteopontin (all P < 0.05) compared to those with CAD alone, but had similar levels of markers of oxidative stress.
Renal function is a determinant of vascular stiffness even in patients with severe atherosclerotic disease. This was paralleled by differences in markers of cell adhesion and inflammation. Increased vascular stiffness may therefore be linked to inflammatory remodeling of the vasculature in people with impaired renal function, irrespective of concomitant atherosclerotic disease.
慢性肾脏病(CKD)和冠状动脉疾病(CAD)均与血管僵硬度增加独立相关。我们研究了肾功能是否独立于CAD状态而对血管僵硬度产生影响。
我们研究了160例CAD患者和169例无CAD的受试者。采用4变量MDRD公式估算肾小球滤过率(eGFR);肾功能受损定义为eGFR<60 mL/分钟。使用SphygmoCor®设备测量颈股脉搏波速度(PWV)。采用xMAP®多重检测技术评估血浆中的循环生物标志物。
与肾功能正常的CAD患者相比,肾功能受损的CAD患者PWV更高(10.2 [9.1;11.2] vs 7.3 [6.9;7.7] m/s;P<0.001)。在所有患者中,即使在调整年龄、性别、收缩压、体重指数以及是否存在CAD后,PWV仍是eGFR的函数(β=-0.293;P<0.001)。与单纯CAD患者相比,肾功能受损的CAD患者的黏附分子和炎症分子(包括E-选择素和骨桥蛋白)水平更高(均P<0.05),但氧化应激标志物水平相似。
即使在患有严重动脉粥样硬化疾病的患者中,肾功能也是血管僵硬度的决定因素。这与细胞黏附和炎症标志物的差异平行。因此,血管僵硬度增加可能与肾功能受损患者血管的炎症重塑有关,而与是否伴有动脉粥样硬化疾病无关。